Related Experiment Video
Updated: May 12, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
An in silico model for interpreting polypharmacology in drug-target networks
Ichigaku Takigawa1, Koji Tsuda, Hiroshi Mamitsuka
1Bioinformatics Center, Institute for Chemical Research, Kyoto University, Kyoto, Japan.
Abstract:
Recent analysis on polypharmacology leads to the idea that only small fragments of drugs and targets are a key to understanding their interactions forming polypharmacology. This idea motivates us to build an in silico approach of finding significant substructure patterns from drug-target (molecular graph-amino acid sequence) pairs. This article introduces an efficient in silico method for enumerating, from given drug-target pairs, all frequent subgraph-subsequence pairs, which can then be further examined by hypothesis testing for statistical significance. Unique features of the method are its scalability, computational efficiency, and technical soundness in terms of computer science and statistics. The presented method was applied to 11,219 drug-target pairs in DrugBank to obtain significant substructure pairs, which can divide most of the original 11,219 pairs into eight highly exclusive clusters, implying that the obtained substructure pairs are indispensable components for interpreting polypharmacology.
Related Concept Videos
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Physiological Pharmacokinetic Models: Assumption with Protein Binding
